Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Retinoid signals and Th17-mediated pathology.

Klemann C, Raveney BJ, Oki S, Yamamura T.

Nihon Rinsho Meneki Gakkai Kaishi. 2009 Feb;32(1):20-8. Review.

2.

Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.

Wu D, Wang J, Pae M, Meydani SN.

Mol Aspects Med. 2012 Feb;33(1):107-18. doi: 10.1016/j.mam.2011.10.001. Epub 2011 Oct 14. Review.

PMID:
22020144
3.

Type 17 T helper cells-origins, features and possible roles in rheumatic disease.

Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S.

Nat Rev Rheumatol. 2009 Jun;5(6):325-31. doi: 10.1038/nrrheum.2009.80. Review.

PMID:
19434074
5.

Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.

Kanai T, Nemoto Y, Kamada N, Totsuka T, Hisamatsu T, Watanabe M, Hibi T.

Curr Opin Gastroenterol. 2009 Jul;25(4):306-13. doi: 10.1097/MOG.0b013e32832bc627. Review.

PMID:
19448533
6.
7.

[Retinoid therapy for autoimmune diseases].

Fukasawa H, Kagechika H, Shudo K.

Nihon Rinsho Meneki Gakkai Kaishi. 2006 Jun;29(3):114-26. Review. Japanese.

8.

Plasticity of CD4+ T cell lineage differentiation.

Zhou L, Chong MM, Littman DR.

Immunity. 2009 May;30(5):646-55. doi: 10.1016/j.immuni.2009.05.001. Review.

9.

[Th17 cells in human rheumatoid arthritis].

Yamada H.

Nihon Rinsho Meneki Gakkai Kaishi. 2009 Aug;32(4):249-55. Review. Japanese.

10.

Interleukin-23/Th17 pathways and inflammatory bowel disease.

Abraham C, Cho J.

Inflamm Bowel Dis. 2009 Jul;15(7):1090-100. doi: 10.1002/ibd.20894. Review.

PMID:
19253307
11.

At the crossroads of T helper lineage commitment-Epigenetics points the way.

Janson PC, Winerdal ME, Winqvist O.

Biochim Biophys Acta. 2009 Sep;1790(9):906-19. doi: 10.1016/j.bbagen.2008.12.003. Epub 2008 Dec 30. Review.

PMID:
19162128
12.

Could retinoids be a potential treatment for rheumatic diseases?

Miyabe Y, Miyabe C, Nanki T.

Rheumatol Int. 2015 Jan;35(1):35-41. doi: 10.1007/s00296-014-3067-2. Epub 2014 Jun 18. Review.

PMID:
24939557
13.

Th17 cells: a third subset of CD4+ T effector cells involved in organ-specific autoimmunity.

Kurts C.

Nephrol Dial Transplant. 2008 Mar;23(3):816-9. Epub 2007 Nov 28. Review. No abstract available.

14.

The different faces of Notch in T-helper-cell differentiation.

Amsen D, Antov A, Flavell RA.

Nat Rev Immunol. 2009 Feb;9(2):116-24. doi: 10.1038/nri2488. Review.

PMID:
19165228
15.

Retinoids, rexinoids and their cognate nuclear receptors: character and their role in chemoprevention of selected malignant diseases.

Brtko J.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007 Dec;151(2):187-94. Review.

16.
17.

Retinoid receptors.

Davidovici BB, Tüzün Y, Wolf R.

Dermatol Clin. 2007 Oct;25(4):525-30, viii. Review.

PMID:
17903611
18.

Autoimmunity: IL-21: a new player in Th17-cell differentiation.

Deenick EK, Tangye SG.

Immunol Cell Biol. 2007 Oct;85(7):503-5. Epub 2007 Sep 4. Review. No abstract available. Erratum in: Immunol Cell Biol. 2008 Jul;86(5):478.

PMID:
17768419
19.

Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications.

Dos Passos GR, Sato DK, Becker J, Fujihara K.

Mediators Inflamm. 2016;2016:5314541. doi: 10.1155/2016/5314541. Epub 2016 Jan 28. Review.

20.

The role of retinoids in the adult nervous system and their therapeutic potential.

Christie VB, Marder TB, Whiting A, Przyborski SA.

Mini Rev Med Chem. 2008 Jun;8(6):601-8. Review.

PMID:
18537715
Items per page

Supplemental Content

Write to the Help Desk